| Aug 11 |
The Immunocore Holdings plc (NASDAQ:IMCR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
|
| Aug 11 |
Immunocore Holdings plc (IMCR) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Immunocore GAAP EPS of -$0.23 beats by $0.24, revenue of $75.4M misses by $0.17M
|
| Aug 8 |
Immunocore reports second quarter financial results and provides a business update
|
| Aug 6 |
3 Small-Cap Stocks with Significant Growth Potential
|
| Aug 1 |
Immunocore to report second quarter 2024 financial results and host call on August 8, 2024
|
| Jul 31 |
Is There An Opportunity With Immunocore Holdings plc's (NASDAQ:IMCR) 32% Undervaluation?
|
| Jul 8 |
2,000 Puts trade in Immunocore Holdings plc (Symbol: IMCR)
|
| Jun 18 |
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
|
| Jun 1 |
Immunocore says new data demonstrates Kimmtrak efficacy for uveal melanoma
|
